- Home
- VRDN vs ERO Comparison
VRDN vs ERO Comparison
Compare VRDN & ERO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRDN
- ERO
- Stock Information
- Founded
- VRDN 2006
- ERO 2016
- Country
- VRDN United States
- ERO Canada
- Employees
- VRDN N/A
- ERO N/A
- Industry
- VRDN Medical Specialities
- ERO
- Sector
- VRDN Health Care
- ERO
- Exchange
- VRDN Nasdaq
- ERO Nasdaq
- Market Cap
- VRDN 1.5B
- ERO 1.5B
- IPO Year
- VRDN N/A
- ERO N/A
- Fundamental
- Price
- VRDN $18.72
- ERO $14.97
- Analyst Decision
- VRDN Strong Buy
- ERO Strong Buy
- Analyst Count
- VRDN 11
- ERO 1
- Target Price
- VRDN $38.80
- ERO $19.00
- AVG Volume (30 Days)
- VRDN 894.1K
- ERO 576.1K
- Earning Date
- VRDN 08-06-2025
- ERO 11-04-2025
- Dividend Yield
- VRDN N/A
- ERO N/A
- EPS Growth
- VRDN N/A
- ERO N/A
- EPS
- VRDN N/A
- ERO 1.38
- Revenue
- VRDN $305,000.00
- ERO $535,974,000.00
- Revenue This Year
- VRDN N/A
- ERO $64.82
- Revenue Next Year
- VRDN $35,092.81
- ERO $30.05
- P/E Ratio
- VRDN N/A
- ERO $10.89
- Revenue Growth
- VRDN 5.90
- ERO 20.59
- 52 Week Low
- VRDN $9.90
- ERO $9.30
- 52 Week High
- VRDN $27.20
- ERO $23.40
- Technical
- Relative Strength Index (RSI)
- VRDN 55.80
- ERO 59.41
- Support Level
- VRDN $18.12
- ERO $14.36
- Resistance Level
- VRDN $20.05
- ERO $15.22
- Average True Range (ATR)
- VRDN 1.02
- ERO 0.44
- MACD
- VRDN -0.02
- ERO 0.13
- Stochastic Oscillator
- VRDN 55.81
- ERO 80.00
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About ERO Ero Copper Corp.
Ero Copper Corp is a base metals mining company. It is predominantly focused on the production and sale of copper with gold and silver produced and sold as by-products. Ero's operations are segmented between its mines in Brazil, the Caraiba Operations and the Xavantina Operations, its development project, the Tucuma Project in Brazil and corporate. Majority of its revenue is generated from its Caraiba Operations segment which consists of mining operations and processing facilities including the Pilar and Vermelhos underground mines and the Surubim open pit mine.